Quarterly report · Q1
2385.TEDINET S100S775
Period2023-07-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2023-07-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥501m | 2023-07-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥496m | 2023-07-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥497m | 2023-07-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥527m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥452m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥528m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥16m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥7.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥8.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥902m | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥-20.15 | 2023-07-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.27 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.53 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 85.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue external | 2023-07-01 → 2023-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥78m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥57m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥57m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥11m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥166m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥166m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥148m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥677m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥676m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥645,000 |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥267m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥71m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥67m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥8m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥157m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥157m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥11m |
| —segment total | revenue | 2023-07-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue external | 2023-07-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥4m |
| —segment total | segment profit | 2023-07-01 → 2023-09-30 | −¥423m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2022-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥77m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥89m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥89m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | −¥13m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥282m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥732m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥732m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2022-09-30 | −¥184m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥23m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥148m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥148m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥15m |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥2.2bn |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥2.2bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥123m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 310
| Item | Context | Value | Unit |
|---|---|---|---|
| Merchandise | Prior1YearInstant | 815853000 | JPY |
| Merchandise | CurrentQuarterInstant | 820782000 | JPY |
| Work in process | Prior1YearInstant | 161009000 | JPY |
| Work in process | CurrentQuarterInstant | 152466000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 319243000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 353834000 | JPY |
| Other ca | Prior1YearInstant | 312650000 | JPY |
| Other ca | CurrentQuarterInstant | 410349000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -35000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -17000 | JPY |
| Current assets | Prior1YearInstant | 7969196000 | JPY |
| Current assets | CurrentQuarterInstant | 7175523000 | JPY |
| Property plant and equipment | Prior1YearInstant | 52041000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 50968000 | JPY |
| Other ia | Prior1YearInstant | 46586000 | JPY |
| Other ia | CurrentQuarterInstant | 46395000 | JPY |
| Intangible assets | Prior1YearInstant | 46586000 | JPY |
| Intangible assets | CurrentQuarterInstant | 46395000 | JPY |
| Investment securities | Prior1YearInstant | 20738000 | JPY |
| Investment securities | CurrentQuarterInstant | 20738000 | JPY |
| Other ioa | Prior1YearInstant | 151419000 | JPY |
| Other ioa | CurrentQuarterInstant | 121912000 | JPY |
| Investments and other assets | Prior1YearInstant | 172157000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 142650000 | JPY |
| Noncurrent assets | Prior1YearInstant | 270785000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 240015000 | JPY |
| Assets | Prior1YearInstant | 8239982000 | JPY |
| Assets | CurrentQuarterInstant | 7415538000 | JPY |
| Accounts payable trade | Prior1YearInstant | 407707000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 158677000 | JPY |
| Income taxes payable | Prior1YearInstant | 43869000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 2392000 | JPY |
| Contract liabilities | Prior1YearInstant | 307374000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 329009000 | JPY |
| Provision for loss on order received cl | Prior1YearInstant | 27207000 | JPY |
| Provision for loss on order received cl | CurrentQuarterInstant | 27207000 | JPY |
| Other cl | Prior1YearInstant | 262880000 | JPY |
| Other cl | CurrentQuarterInstant | 364873000 | JPY |
| Current liabilities | Prior1YearInstant | 1049039000 | JPY |
| Current liabilities | CurrentQuarterInstant | 882159000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 18725000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 18440000 | JPY |
| Other ncl | Prior1YearInstant | - | JPY |
| Other ncl | CurrentQuarterInstant | 1481000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 18725000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 19921000 | JPY |
| Liabilities | Prior1YearInstant | 1067764000 | JPY |
| Liabilities | CurrentQuarterInstant | 902081000 | JPY |
| Capital stock | Prior1YearInstant | 1836587000 | JPY |
| Capital stock | CurrentQuarterInstant | 1836587000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |